Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1111/tid.13371

http://scihub22266oqcxt.onion/10.1111/tid.13371
suck pdf from google scholar
32657540!7404438!32657540
unlimited free pdf from europmc32657540    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid32657540      Transpl+Infect+Dis 2020 ; 22 (5): e13371
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • COVID-19 in kidney transplant recipients: A multicenter experience in Istanbul #MMPMID32657540
  • Demir E; Uyar M; Parmaksiz E; Sinangil A; Yelken B; Dirim AB; Merhametsiz O; Yadigar S; Atan Ucar Z; Ucar AR; Demir ME; Mese M; Akin EB; Garayeva N; Safak S; Oto OA; Yazici H; Turkmen A
  • Transpl Infect Dis 2020[Oct]; 22 (5): e13371 PMID32657540show ga
  • INTRODUCTION: Management of COVID-19 in kidney transplant recipients should include treatment of the infection, regulation of immunosuppression, and supportive therapy. However, there is no consensus on this issue yet. This study aimed to our experiences with kidney transplant recipients diagnosed with COVID-19. MATERIAL AND METHODS: Kidney transplant recipients diagnosed with COVID-19 from five major transplant centers in Istanbul, Turkey, were included in this retrospective cohort study. Patients were classified as having moderate or severe pneumonia for the analysis. The primary endpoint was all-cause mortality. The secondary endpoints were acute kidney injury, the average length of hospital stay, admission to intensive care, and mechanical ventilation. RESULTS: Forty patients were reviewed retrospectively over a follow-up period of 32 days after being diagnosed with COVID-19. Cough, fever, and dyspnea were the most frequent symptoms in all patients. The frequency of previous induction and rejection therapy was significantly higher in the group with severe pneumonia compared to the moderate pneumonia group. None of the patients using cyclosporine A developed severe pneumonia. Five patients died during follow-up in the intensive care unit. None of the patients developed graft loss during follow-up. DISCUSSION: COVID-19 has been seen to more commonly cause moderate or severe pneumonia in kidney transplant recipients. Immunosuppression should be carefully reduced in these patients. Induction therapy with lymphocyte-depleting agents should be carefully avoided in kidney transplant recipients during the pandemic period.
  • |Adult[MESH]
  • |Aged[MESH]
  • |Antibodies, Monoclonal, Humanized/therapeutic use[MESH]
  • |Antiviral Agents/therapeutic use[MESH]
  • |COVID-19 Nucleic Acid Testing[MESH]
  • |COVID-19/diagnosis/immunology/*therapy[MESH]
  • |Critical Care/methods/standards[MESH]
  • |Dose-Response Relationship, Drug[MESH]
  • |Drug Administration Schedule[MESH]
  • |Drug Therapy, Combination/methods/standards[MESH]
  • |Female[MESH]
  • |Follow-Up Studies[MESH]
  • |Graft Rejection/immunology/prevention & control[MESH]
  • |Humans[MESH]
  • |Immunosuppression Therapy/adverse effects/methods/*standards[MESH]
  • |Immunosuppressive Agents/administration & dosage/*adverse effects[MESH]
  • |Intensive Care Units/standards[MESH]
  • |Interleukin 1 Receptor Antagonist Protein/therapeutic use[MESH]
  • |Kidney Transplantation/*adverse effects[MESH]
  • |Male[MESH]
  • |Middle Aged[MESH]
  • |Patient Admission/standards[MESH]
  • |Practice Guidelines as Topic[MESH]
  • |Respiration, Artificial/standards[MESH]
  • |Retrospective Studies[MESH]
  • |SARS-CoV-2/genetics/*immunology/isolation & purification[MESH]
  • |Severity of Illness Index[MESH]
  • |Transplant Recipients[MESH]
  • |Treatment Outcome[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box